W. Gregory Alvord
About
W. Gregory Alvord is a scholar working on Immunology, Molecular Biology and Virology.
According to data from OpenAlex, W. Gregory Alvord has authored 122 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Immunology, 42 papers in Molecular Biology and 34 papers in Virology. Recurrent topics in W. Gregory Alvord's work include HIV Research and Treatment (34 papers), Immunotherapy and Immune Responses (22 papers) and Immune Cell Function and Interaction (21 papers). W. Gregory Alvord is often cited by papers focused on HIV Research and Treatment (34 papers), Immunotherapy and Immune Responses (22 papers) and Immune Cell Function and Interaction (21 papers). W. Gregory Alvord collaborates with scholars based in United States, Japan and France. W. Gregory Alvord's co-authors include Michael Baseler, H. Clifford Lane, Richard A. Lempicki, Jean Roayaei, Brad T. Sherman, Robert D. Stephens, Jack Collins, Frederick G. Hayden, Stephen E. Straus and Warren Strober and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
In The Last Decade
W. Gregory Alvord
121 papers receiving 8.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| W. Gregory Alvord United States | 43 | 3.3k | 2.5k | 1.5k | 1.3k | 1.2k | 122 | 8.4k | ||
| Shohreh Amini United States | 40 | 3.2k 1.0× | 1.9k 0.8× | 934 0.6× | 1.5k 1.2× | 1.8k 1.5× | 146 | 7.8k | ||
| Giorgio Zauli Italy | 60 | 6.1k 1.8× | 3.9k 1.6× | 1.5k 1.0× | 2.7k 2.1× | 2.0k 1.7× | 381 | 13.0k | ||
| Florian Kern United States | 51 | 2.6k 0.8× | 2.9k 1.2× | 3.5k 2.4× | 2.0k 1.6× | 622 0.5× | 216 | 9.4k | ||
| Florence M. Hofman United States | 56 | 2.9k 0.9× | 2.8k 1.1× | 2.0k 1.4× | 1.4k 1.1× | 329 0.3× | 172 | 9.6k | ||
| David J. Kelvin Canada | 56 | 3.0k 0.9× | 4.3k 1.7× | 1.9k 1.3× | 2.3k 1.8× | 769 0.7× | 180 | 10.5k | ||
| Karin Moelling Germany | 49 | 6.3k 1.9× | 1.6k 0.7× | 1.1k 0.7× | 1.3k 1.0× | 1.4k 1.2× | 220 | 9.9k | ||
| Michael Eckhaus United States | 47 | 4.8k 1.4× | 2.0k 0.8× | 1.3k 0.9× | 1.5k 1.2× | 383 0.3× | 114 | 10.2k | ||
| Tomozumi Imamichi United States | 28 | 2.8k 0.8× | 1.5k 0.6× | 643 0.4× | 554 0.4× | 1.0k 0.9× | 89 | 6.1k | ||
| Michel Samson France | 51 | 2.6k 0.8× | 4.9k 2.0× | 1.3k 0.9× | 1.5k 1.1× | 3.1k 2.6× | 154 | 9.5k | ||
| Mikael Jondal Sweden | 55 | 3.2k 1.0× | 6.4k 2.6× | 1.6k 1.1× | 2.8k 2.1× | 679 0.6× | 199 | 12.2k |
Countries citing papers authored by W. Gregory Alvord
Since
Specialization
Citations
This map shows the geographic impact of W. Gregory Alvord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Gregory Alvord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Gregory Alvord more than expected).
Fields of papers citing papers by W. Gregory Alvord
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by W. Gregory Alvord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Gregory Alvord. The network helps show where W. Gregory Alvord may publish in the future.
Co-authorship network of co-authors of W. Gregory Alvord
This figure shows the co-authorship network connecting the top 25 collaborators of W. Gregory Alvord. A scholar is included among the top collaborators of W. Gregory Alvord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Gregory Alvord. W. Gregory Alvord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Nikolaitchik, Olga A., Brandon F. Keele, Robert J. Gorelick, et al.. (2015). High recombination potential of subtype A HIV-1. Virology. 484. 334–340.
2.
Abram, Michael E., Andrea L. Ferris, Wei Shao, W. Gregory Alvord, & Stephen H. Hughes. (2010). Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication. Journal of Virology. 84(19). 9864–9878.
3.
Kuhns, Douglas B., W. Gregory Alvord, Theo Heller, et al.. (2010). Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease. New England Journal of Medicine. 363(27). 2600–2610.
4.
Sato, Takashi, Takeshi Shimosato, W. Gregory Alvord, & Dennis M. Klinman. (2008). Suppressive Oligodeoxynucleotides Inhibit Silica-Induced Pulmonary Inflammation. The Journal of Immunology. 180(11). 7648–7654.
5.
McWilliams, Mary Jane, John G. Julias, Stefan G. Sarafianos, et al.. (2006). Combining mutations in HIV-1 reverse transcriptase with mutations in the HIV-1 polypurine tract affects RNase H cleavages involved in PPT utilization. Virology. 348(2). 378–388.
6.
Pinczewski, Joel, Jun Zhao, Nina Malkevitch, et al.. (2005). Enhanced Immunity and Protective Efficacy against SIV mac251 Intrarectal Challenge Following Ad-SIV Priming by Multiple Mucosal Routes and gp120 Boosting in MPL-SE. Viral Immunology. 18(1). 236–243.
7.
Lekstrom-Himes, Julie, Douglas B. Kuhns, W. Gregory Alvord, & John I. Gallin. (2005). Inhibition of Human Neutrophil IL-8 Production by Hydrogen Peroxide and Dysregulation in Chronic Granulomatous Disease. The Journal of Immunology. 174(1). 411–417.
8.
Lifson, Jeffrey D., Jeffrey L. Rossio, Michael Piatak, et al.. (2004). Evaluation of the Safety, Immunogenicity, and Protective Efficacy of Whole Inactivated Simian Immunodeficiency Virus (SIV) Vaccines with Conformationally and Functionally Intact Envelope Glycoproteins. AIDS Research and Human Retroviruses. 20(7). 772–787.
9.
Malkevitch, Nina, L. Jean Patterson, Kristine Aldrich, et al.. (2003). A Replication Competent Adenovirus 5 Host Range Mutant-Simian Immunodeficiency Virus (SIV) Recombinant Priming/Subunit Protein Boosting Vaccine Regimen Induces Broad, Persistent SIV-Specific Cellular Immunity to Dominant and Subdominant Epitopes in Mamu-A*01 Rhesus Macaques. The Journal of Immunology. 170(8). 4281–4289.
10.
Poehlein, Christian, Hong‐Ming Hu, Ilka Assmann, et al.. (2003). TNF Plays an Essential Role in Tumor Regression after Adoptive Transfer of Perforin/IFN-γ Double Knockout Effector T Cells. The Journal of Immunology. 170(4). 2004–2013.
11.
Wigginton, Jon M., Jong‐Keuk Lee, T A Wiltrout, et al.. (2002). Synergistic Engagement of an Ineffective Endogenous Anti-Tumor Immune Response and Induction of IFN-γ and Fas-Ligand-Dependent Tumor Eradication by Combined Administration of IL-18 and IL-2. The Journal of Immunology. 169(8). 4467–4474.
12.
Hildesheim, Jeffrey, Dmitry V. Bulavin, Miriam R. Anver, et al.. (2002). Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53.. PubMed. 62(24). 7305–15.
13.
Patterson, L. Jean, Gregory A. Prince, Ersell Richardson, et al.. (2002). Insertion of HIV-1 Genes into Ad4ΔE3 Vector Abrogates Increased Pathogenesis in Cotton Rats Due to E3 Deletion. Virology. 292(1). 107–113.
14.
Patterson, L. Jean, Frank A. Robey, Kristine Aldrich, et al.. (2001). A Conformational C4 Peptide Polymer Vaccine Coupled with Live Recombinant Vector Priming Is Immunogenic But Does Not Protect against Rectal SIV Challenge. AIDS Research and Human Retroviruses. 17(9). 837–849.
15.
Kuhns, Douglas B., Edward L. Nelson, W. Gregory Alvord, & John I. Gallin. (2001). Fibrinogen Induces IL-8 Synthesis in Human Neutrophils Stimulated with Formyl-Methionyl-Leucyl-Phenylalanine or Leukotriene B4. The Journal of Immunology. 167(5). 2869–2878.
16.
Fritz, Richard, Frederick G. Hayden, David P. Calfee, et al.. (1999). Nasal Cytokine and Chemokine Responses in Experimental Influenza A Virus Infection: Results of a Placebo‐Controlled Trial of Intravenous Zanamivir Treatment. The Journal of Infectious Diseases. 180(3). 586–593.
17.
Hayden, Frederick G., et al.. (1998). Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.. Journal of Clinical Investigation. 101(3). 643–649.
18.
Janik, John E., L.L. Miller, Daniele Longo, et al.. (1996). Phase II Trial of Interleukin 1 and Indomethacin in Treatment of Metastatic Melanoma. JNCI Journal of the National Cancer Institute. 88(1). 44–49.
19.
Smith, John W., W. Gregory Alvord, John E. Janik, et al.. (1993). The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin. New England Journal of Medicine. 328(11). 756–761.
20.
Ewel, C., Walter J. Urba, William C. Kopp, et al.. (1992). Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.. PubMed. 52(11). 3005–10.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Shohreh Amini Breakdown of academic impact, for papers by Giorgio Zauli Breakdown of academic impact, for papers by Florian Kern Breakdown of academic impact, for papers by Florence M. Hofman Breakdown of academic impact, for papers by David J. Kelvin Breakdown of academic impact, for papers by Karin Moelling Breakdown of academic impact, for papers by Michael Eckhaus Breakdown of academic impact, for papers by Tomozumi Imamichi Breakdown of academic impact, for papers by Michel Samson Breakdown of academic impact, for papers by Mikael Jondal